Skip to main content
Yelena Janjigian, MD, Oncology, New York, NY, Memorial Sloan-Kettering Cancer Center

YelenaYJanjigianMD

Oncology New York, NY

Gastrointestinal Cancer

Chief, GI Oncology Service Memorial Sloan Kettering Cancer Center

Overview of Dr. Janjigian

Dr. Yelena Janjigian is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan-Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. She received her medical degree from New York University Grossman School of Medicine and has been in practice 14 years. Dr. Janjigian accepts several types of health insurance, listed below. She is one of 468 doctors at Memorial Sloan-Kettering Cancer Center and one of 82 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Oncology. She has more than 100 publications and over 500 citings.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2006 - 2009
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Internal Medicine, 2003 - 2006
  • New York University School of Medicine
    New York University School of MedicineClass of 2003

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NY State Medical License
    NY State Medical License 2006 - 2025
  • NJ State Medical License
    NJ State Medical License 2019 - 2025
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Indications for Total Gastrectomy in CDH1 Mutation Carriers and Outcomes of Risk-Reducing Minimally Invasive and Open Gastrectomies  
    Sam S Yoon, Yelena Janjigian, Daniel G Coit, Zsofia K Stadler, Vivian E Strong, JAMA Surgery
  • YES1 Amplification Is a Mechanism of Acquired Resistance to EGFR Inhibitors Identified by Transposon Mutagenesis and Clinical Genomics  
    Emmet J Jordan, Helena A Yu, Yelena Y Janjigian, Mark G Kris, Paul K Paik, Jamie E Chaft, Lu Wang, Gregory J Riely, Proceedings of the National Academy of Sciences

Lectures

  • Biomarkers to Guide Surveillance and Adjuvant Therapy of Early-Stage Disease 
    ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020
  • Biomarkers for Better Treatment and Patient Selection 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019
  • Checkpoint Blockade in Esophagogastric Cancer 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019

Authored Content

  • Combination Therapies: The Wave of the FutureJanuary 2019
  • Checkpoint Blockade in Esophagogastric CancerJune 2018

Press Mentions

  • Agenus (AGEN) Q1 2023 Earnings Call Transcript
    Agenus (AGEN) Q1 2023 Earnings Call TranscriptMay 9th, 2023
  • Transcenta to Present Two Clinical Trial Progress at ASCO 2023
    Transcenta to Present Two Clinical Trial Progress at ASCO 2023May 8th, 2023
  • Zolbetuximab Improves Survival in Gastric Cancer
    Zolbetuximab Improves Survival in Gastric CancerMarch 26th, 2023
  • Join now to see all

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    BCBS Texas BlueChoice
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    First Health PPO
    GHI PPO
    Great West PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    QualCare HMO
    QualCare PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment